ARCHIVES

Trials show No Advantage for ABMT In Breast Cancer; Should Insurers Pay?

This article is from The Cancer Letter archive.

Vol. 25 No. 15 | April 16, 1999

Download PDF Visit The Full Archive

Related Articles

NCAB Approves New Pancreatic Cancer Project, Hears Favorable Reports On Organ site Programs

November 29, 1974

Genetic Risk Factor Implicated In Prostate Cancer In Blacks

August 25, 2006

Organ Systems Program Progress, Momentum Threatened During transition, Karr Contends

December 9, 1988

Guest Editorial By Gregory Reaman: Memories Of A Merger Past

July 15, 2011

Women 80 And Older Benefit From Mammography

May 30, 2008

Adherez Issued U.S. Patent for Catenin Molecule Inhibition.

July 4, 2003